Johnson & Johnson Innovation – JJDC — Full Portfolio

Rapport is a biopharmaceutical company developing novel therapeutics.

BiotechHealthtechMedical Devices

ACAbe Ceesay(President)CGCheryl GaultinDr. SevignyAbraham N. Ceesay(President and Chief Executive Officer and Director)Steven Paul David Bredt(Founder)

Co-investorsARARCH Venture PartnersSOSofinnova VenturesCACapital GroupTHThird Rock Ventures

Veracyte develops genomic diagnostic tests for cancer, offering laboratory developed tests for thyroid, prostate, bladder, and breast cancers performed in its CLIA-certified, high-complexity labs.

BiotechHealthtechMedical DevicesSouth San Francisco, US

BHBonnie H. Anderson(Executive Officer, Director)inJBJulie Brooks(Executive Officer)inSDShelly D. Guyer(Executive Officer)inMarc Stapley(Chief Executive Officer)in

BoardSamuel D. Colella(Director)Fred E. Cohen(Director)

Co-investorsCACatalyst Health VenturesKLKleiner PerkinsDODomain Associates

Biotech

Co-investorsKUKurma PartnersSOSofinnova PartnersM M VenturesSRSR One Capital ManagementEQEQT Life Sciences

Bright Peak Therapeutics is a biotechnology company developing multi-functional PD-1 inhibitors for cancer immunotherapy, based on its EDC protein-engineering platform.

BiotechHealthtechSan Diego, US

VPVijaya Pattabiraman(Co-founder & Chief Technology Officer)inJBJeffrey Bode(Scientific co-founder)inFWFredrik Wiklund(Chief Executive Officer)Christine Siu(Director)Michael Rosenzweig(Director)Bertolt Kreft(Executive Officer)

Co-investorsRARA CapitalVEVersant VenturesVEVenrockALAlexandriaBLBlackRockFIFidelity Investments+2 more

Citryll is a clinical-stage biotech developing CIT-013, an antibody therapy that targets extracellular traps by selectively binding citrullinated histones to both inhibit new trap formation and clear existing ones.

BiotechHealthtechMedical DevicesOss, NL

RCRenato Chirivi(Co-founder (former CSO))in

BoardPaul Peter Tak(Chair of the Board)

Co-investorsBIBioGeneration VenturesPUPureos BioventuresSESeventure PartnersFOForbionBOBOMCUCurie Capital+1 more

CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.

BiotechHealthtechSan Carlos, US

AFAnthony Ford(Executive Officer, Director)inBenjamin Potter(Executive Officer)Henry Skinner(Director)LRLiam Ratcliffe(Director)in

BoardRHRon Hunt(Director)inLoretta Tse, Ph.D.(Director)

Co-investorsALAlta PartnersLOLongitude CapitalABabrdn plcINIntermediate Capital GroupNENew Leaf Venture PartnersPAPappas Capital+2 more

Loci Orthopaedics develops extremity orthopaedic technologies, including its InDx device for the thumb base joint, using evidence-based design to address unmet clinical needs.

HealthtechMedical DevicesGalway, IE

BBBrendan Boland(Co-founder & Executive Chairperson)Gerry(Co-founder)Barry(CEO)Paul(Finance Leader)John(VP Technical Operations)

Co-investorsSESeroba Life SciencesENEnterprise IrelandLALaunch Capital

Mestag is an immunology company developing first-in-class treatments for cancer and inflammatory diseases by leveraging novel understanding of fibroblast biology and tertiary lymphoid structures.

AI & Machine LearningBiotechDigital HealthHealthtechLondon, GB

Michael B. Brenner(Founder)Chris Buckley(Founder)MCMark Coles(Founder)inSRSoumya Raychaudhuri(Founder)DADavid A. Tuveson(Founder)Lindsey Rolfe(Chief Medical Officer)in

Co-investorsGVGV (Google Ventures)SVSV Health InvestorsFOForbionNONorthpond VenturesJJJJDC

ONL Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve sight by preventing Fas-mediated death of retinal cells, a cause of vision loss and blindness.

BiotechHealthtechMedical DevicesAnn Arbor, US

DZDavid Zacks(Co-Founder & Chief Scientific Officer)inDEDavid Esposito(Executive Officer, Director)inConstance Chang(Executive Officer)JKJohn K Freshley(Executive Officer, Director)inJAJeffrey A Jamison(Executive Officer)in

BoardAFAaron Fletcher(Director)in

Co-investorsEXExSight VenturesINInvest MichiganNONovartis Venture FundVIVisionary VenturesBIBios PartnersINInFocus Capital Partners, LLC+3 more

Orasis is a pharmaceutical company developing drugs for the eye, operating in the ophthalmology and eyecare space.

BiotechHealthtechMedical Devices

Co-investorsARArboretum VenturesMAMaverick Ventures IsraelVIVisionary VenturesCACatalio Capital ManagementLILifeSci Venture PartnersSESequoia Capital+1 more

SpectraWAVE develops optical and computational imaging technologies to diagnose and guide treatment decisions for patients with coronary artery disease and cardiovascular disease.

AI & Machine LearningDeep TechHealthtechMedical DevicesBedford, US

ENEman Namati(President & CEO)inGTGuillermo Tearney(Founder; Professor of Pathology, Massachusetts General Hospital)GSGregg Stone(Founder; Professor of Medicine, Mount Sinai Heart Health System)JMJames Muller(Founder; Cardiologist, Brigham and Women's Hospital)inJeffrey O'Donnell(Founder; Managing General Partner, Runway Healthcare)VWVivek Walimbe(Chief Operating Officer)in

Co-investorsLULumira VenturesS3S3 VenturesSVSV Health InvestorsDEDeerfield Management Company

Georgiamune is a biopharmaceutical company developing targeted immunomodulator drugs that activate or down-modulate immune signaling pathways to treat cancer and autoimmune diseases.

BiotechDeep TechHealthtechGaithersburg, US

SNSamir N. Khleif(Founder & CEO)inRIRamy Ibrahim(Chief Medical and Strategy Officer)inMMMikayel Mkrichyan(Senior Vice President of Science and Discovery)SSSarah Sharman(Vice President of IP Legal Affairs)

BoardSPSean Parker(Director)EVElena Viboch(Director)in

Board seatNancy Ondovik· per SEC Form D · $131.9M raise · filed Aug 2026

Co-investorsCACatalio Capital Management, LPGEGeneral CatalystHAHAWKTAILLALauder PartnersPRPrevail Venture CapitalALAlexandria+3 more

Accent Therapeutics is a biotechnology company focused on discovering and developing small molecule drugs to improve health outcomes for cancer patients.

BiotechHealthtechLongevity

Co-investorsATAtlas VentureDRDroia VenturesECEcoR1 CapitalGVGV (Google Ventures)THThe Column GroupABAbbVie+3 more

Jean-Paul Clozel(Founder)

Co-investorsRIRidgeback CapitalSOSofinnova Ventures

Alessa develops SaaS compliance software that combines KYC, KYB, AML, and fraud prevention tools for financial institutions and corporates globally.

CybersecurityEnterprise SoftwareFintechSaaSJamaica, JM

HSHolly Sais Phillippi(Chief Executive Officer)in

Co-investorsMAMassMutual VenturesMIMission BiocapitalSASalesforce VenturesWAWavecrest Growth Partners

Aro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins.

BiotechHealthtechPhiladelphia, US

KOKaryn O'Neil(Executive Officer, Director)Susan Dillon(Founder)inMark V. Laurenzi(Executive Officer)

BoardElizabeth Anderson(Director)BPBruce Peacock(Director)

Co-investorsAVAvego BioScience CapitalHEHealthCapAGAgent CapitalBIBiotechnology Value FundCOCowen Healthcare InvestmentsNONorthpond Ventures

ARO Network is an edge network infrastructure platform designed for AI agents to operate on local devices and residential networks using users' real-world resources.

AI & Machine LearningCrypto & Web3Data & Infrastructure

Co-investorsCVCVP NoLimitEVEv3 Ventures LlcNONo Limit Holdings (NLH)1717SigmaNONorte VenturesONOnevc Venture Partners Llc

Astraveus develops the Lakhesys Benchtop Cell Factory, a microfluidic-based bioprocessing platform for scaling cell and gene therapy manufacturing with improved quality and cost efficiency.

BiotechDeep TechMedical DevicesParis, FR

Jérémie Laurent(Chief Executive Officer)

Co-investorsADAdBio partnersM M Ventures

Developer of a surgical robotic system for minimally invasive endoscopy and laparoscopy

Frederic Moll(Founder)

Co-investorsBEBeast VenturesLULux CapitalMIMithril Capital ManagementPRPractica CapitalSBSBI Investment Korea Co. Ltd.SOSonder Capital+5 more

Baebies develops multifunctional syndromic diagnostic testing using proprietary digital microfluidics, integrating molecular, immunoassay, chemistry, and coagulation testing into a single compact platform (FINDER) that runs on small-volume samples.

BiotechDeep TechDigital HealthHealthtechMedical DevicesResearch Triangle Park, US

VPVamsee Pamula(Executive Officer, Director)in

BoardDennis Sacha(Director)William A. Hawkins(Director)

Co-investorsCHCharlotte Angel FundDUDuke Capital PartnersIAIAG Capital PartnersRERex Health VenturesSOSolas BioVenturesVEVentureSouth+1 more

Cellular Origins provides automated cell therapy manufacturing solutions through its Constellation platform, which integrates robotics and digital management to enable GMP-compliant scaling of cell therapies with minimal process modification.

Advanced ManufacturingBiotechRoboticsCambridge, GB

Alex Lang(Founder)

Co-investorsHIHighland EuropeNYNYBC VenturesTTTTP VenturesBUBusiness Growth Fund

Cornerstone provides expert-guided AI software that organizes, standardizes, and harmonizes life science data from clinical trials, labs, and EHRs to produce analysis-ready datasets.

AI & Machine LearningBiotechData & InfrastructureDigital HealthHealthtech

Andrew Howland(Founder)inCOClara Oromendia(Founder)inVNViraj NarayananinMichael Elashoff(Founder)

Co-investorsACAcrew CapitalHEHealthy VenturesINInitiate Venture Partners

Covid test maker that went public at a $2.3 billion valuation.

CSClint Sever(Founder)in

Co-investorsACACME CapitalDADarwin CapitalDEDecheng CapitalDEDentsu VenturesFOForesite CapitalMOMothership VC+4 more

Datavant Connect is a data connectivity platform that enables healthcare and life sciences organizations to share and link datasets while maintaining privacy compliance through tokenization technology.

AI & Machine LearningData & InfrastructureDigital HealthEnterprise SoftwareHealthtech

KAKyle Armbrester(Chief Executive Officer)in

Co-investorsFLFlex Capital PartnersGRGrand VenturesHEHealth Catalyst CapitalMEMerck Global Health Innovation FundMSMSD Global Health Innovation FundOCOctave+3 more

Frontier is a drug discovery company developing small-molecule covalent drugs aimed at previously undruggable protein targets across the proteome.

AI & Machine LearningBiotechSouth San Francisco, US

CVChris Varma, Ph.D.(Executive Officer, Director)CVChris Varma(Co-founder, Chairman and CEO)inJim Winkler(Executive Officer)JHJohannes Hermann, Ph.D.(Executive Officer)KWKevin Webster(Executive Officer)inGregory Chow(Executive Officer)

Co-investorsBEBerkeley CatalystDCDCVC (Data Collective)DRDroia VenturesFEFelicis VenturesMPMPM BioImpactRARA Capital+2 more

Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.

BiotechHealthtech

JVJohn Valliant(Founder)in

Co-investorsFAFACIT (Fight Against Cancer Innovation Trust)HEHealthCapLULumira VenturesPIPivotal Life SciencesSESeroba Life SciencesVEVenture Ontario+6 more

BiotechSan Diego, US

Han Ying(Director)Usman Nassim(Director)Weiguo Yu(Executive Officer)Renate Parry(Director)Ying Luo(Director)inSongjiang Ma(Director, Executive Officer)

HistoSonics develops histotripsy technology, a non-invasive method that uses focused sound energy to destroy targeted tissue, offered as a medical device for physicians and their patients.

BiotechHardwareHealthtechMedical DevicesAnn Arbor, GB

TDThomas Davison(Executive Officer, Director)inMCM. Christine Gibbons(Executive Officer, Director)inWen Chen(Director)Tom Tefft(Director)Michael Blue(Executive Officer, Director)Fred Lee(Director)

Co-investorsALAlpha Wave GlobalAMAmzak HealthARArboretum VenturesEAEarly Stage Partners, LPHEHealthQuest CapitalK5K5 Global+7 more

HYALEX Orthopaedics develops a synthetic cartilage platform for joint repair in orthopaedic surgery.

HealthtechMedical DevicesLexington, US

CVCarl Vause(Executive Officer, Director)inMSMira Sahney(Executive Officer, Director)inDMDavid Myung(Director)

BoardMichael Hawkins(Director)WHWende Hutton(Director)inWHWilliam Harrington(Director)in

Co-investorsCACanaan PartnersOUOUP (Osage University Partners)TRTreo Ventures, Llc

iOnctura is a clinical-stage drug development company developing precision oral small-molecule therapies targeting the tumor-stroma-immune interface, with a pipeline including roginolisib and cambritaxestat in cancers such as uveal melanoma and pancreatic cancer.

BiotechDeep TechHealthtechMedical Devices

CPCatherine Pickering(Co-Founder & CEO)inLVLars van der Veen(Co-Founder & CSO)inMLMichael Lahn(CMO)inEHElizabeth Holt(CBO)inSSSteven Sciuto(CFO)inMTMichelle Tsai(COO)in

Co-investorsINInkef3B3B Future Health FundM M VenturesVIVI PartnersXGXGEN Venture

MEMEBOX (미미박스/MBX) is a global beauty company that builds and sells K-beauty brands and products, marketed to consumers in over 40 countries.

ConsumerDirect to ConsumerE-commerceSeoul, KR

H(Hyungseok (Dino) Ha(CEO)inHHHyungseok Ha(CEO / Representative)inDino Ha(Founder)Pat

Co-investorsCLClick VenturesCOCota CapitalCOCowboy VenturesFUFundersClubMOMontage CapitalOROrbiMed+14 more

Medcrypt provides cybersecurity products and strategic consulting to medical device manufacturers to ensure their devices are secure by design and meet FDA regulatory requirements.

CybersecurityHealthtechMedical DevicesSaaSSan Diego, US

EPEric Pancoast(CTO)inMKMike Kijewski(CEO)inVMVidya Murthy(VP of Operations)inWilliam Fenstermaker(Founder)Om Mahida(Engineer)Erin Murphree(talent acquisition)

Co-investorsENEniac VenturesINIntuitive VenturesY Y CombinatorSESection 32ALAlumni VenturesANAnzu Partners+10 more

Moon Surgical develops the Maestro robotic surgery system, a digital surgical robotics platform used by surgeons to perform procedures.

HealthtechMedical DevicesRoboticsParis, FR

BGBrice Gayet(Founder)inAOAnne Osdoit(Chief Executive Officer)inEEEric Ermenault(Chief Commercial Officer)inARAnne Renevot(Chief Financial Officer)inVFViola Fleig(Chief Operations Officer)inDNDavid Noonan(Chief Technology Officer)in

Co-investorsNVNVIDIASOSofinnova PartnersCACathay HealthSTStar51 CapitalNVNVentures

HealthtechPleasanton, US

TLTed Lamson(Founder)inDavid Amerson(Executive Officer, Director)William Facteau(Director)Joshua Makower(Director)Theodore Lamson(Founder)

BoardRyan Drant(Director)

Co-investorsNENew Enterprise Associates (NEA)WIWindham Capital Partners

Modern nail care brand offering high-quality, salon-grade products and tools for at-home manicures and pedicures.

Beverly Hills, US

SGSarah Gibson Tuttle(Executive Officer, Director)in

Co-investorsALAlpha Edison

PhaseBio is a company focused on developing treatments for cardiovascular disease, which is a leading cause of death in the United States.

BiotechHealthtechMedical DevicesMalvern, US

Ashutosh Chilkoti(Director)Joel Sussman(Executive Officer)JMJonathan Mow(Chief Executive Officer)in

BoardJames Barrett(Director)Michael Gutch(Director)Justin Klein(Director)

Co-investorsMOMountain Group CapitalNENew Enterprise Associates (NEA)HAHatteras Venture Partners

HealthtechBelmont, US

Barry Cheskin(Executive Officer, Director)S. Arieh Zak(Executive Officer)George Green(Executive Officer)

BoardDrew Schiff(Director)Michael Carusi(Director)Lou Bock(Director)

Co-investorsAIAisling CapitalARArcher Capital GroupARArcher Venture CapitalLILightstone VenturesFRFrazier Life SciencesSCScale Venture Partners

HealthtechHouston, US

JNJoanna Nathan(Executive Officer, Director)in

BoardMicheal Haimour(Director)Ed Boyle(Director)Sean Churchill(Director)

Co-investorsHOHouston Angel NetworkNENew World AngelsTMTMC Venture Fund

Pulmocide is a biopharmaceutical company developing inhaled therapies for difficult-to-treat respiratory diseases, currently focused on respiratory fungal infections such as pulmonary aspergillosis.

BiotechHealthtech

PSPete Strong(Co-founder)Garth Rapeport(Co-founder)inKazuhiro Ito(Co-founder)inJohn Murray(Co-founder)inDMDavid Mantusin

Co-investorsADAdjuvant CapitalASAsahi Kasei Corporate Venture CapitalDEDementia Discovery FundF-F-Prime CapitalJEJeito CapitalLOLongwood Fund+4 more

Rondo Therapeutics is an immuno-oncology biopharmaceutical company developing bispecific/multispecific antibody therapeutics designed for tumor-selective targeting to treat solid tumors while sparing healthy tissue.

BiotechHealthtech

SFShelley Force Aldred(Co-Founder & Chief Executive Officer)inNTNathan Trinklein(Co-Founder, President & CSO)inKatherine(Chief Development Officer)Thomas(Chief Medical Officer)

Co-investorsCACanaan PartnersDEDementia Discovery FundRERed Tree VentureSVSV Health InvestorsNONovo Holdings

Rosebud AI provides generative AI tools that enable users to create games and immersive interactive experiences without requiring extensive technical expertise.

AI & Machine LearningConsumerCreator EconomyDeveloper ToolsGamingSan Francisco, US

LLLisha Li(Founder)inMei Liu(Eng Lead)Dzmitry Pletnikau(Founding Engineer)Eric Liu(Intern)Alexandru Barbur(Head of Eng)Kat Dar(EA)

Co-investors2A2am VCANAngel Collective Opportunity FundFOFoothill VenturesKHKhosla VenturesSOSoma CapitalVEVentek+15 more

Solenic Medical is a medical company; this page is an investor contact form and does not describe the company's products or technology in detail.

Medical DevicesCollege Station, US

JYJames Y Lancaster(Executive Officer, Director)in

BoardJohn Hodock(Director)Robert Calvin Goforth(Director)

Co-investorsSHShangBay Capital LLCSUSugati Ventures

SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound-mediated delivery) to deliver genetic payloads to targeted sites in a redosable way.

BiotechDeep TechDigital HealthHealthtechSouth San Francisco, US

KGKenneth Greenberg(Co-Founder, President & CEO)in

Co-investorsVIVida VenturesLELeaps by BayerARARCH Venture PartnersFOFoothill VenturesILIllumina VenturesMEMedical Excellence Capital+8 more

HealthtechLexington, US

Michael Cima, Ph.D.(Director)RDRahul Dhanda(Senior Vice President, Corporate Development)inJMJohn McDonough(Chief Executive Officer)inTom Lowery, Ph.D.(Chief Scientific Officer)Michael Gibbs, Esq.(Vice President and General Counsel)Joanne Spadoro, Ph.D.(Chief Operating Officer)in

Co-investorsAIAisling CapitalAPAPERTURE Venture PartnersINIn-Q-TelARArcus VenturesFLFlagship VenturesFLFlybridge Capital Partners+2 more

HealthtechStamford, US

Patrick Lopath(Chief Operating Officer)inThomas Alan Dunlap(Chief Executive Officer)Madhu Ayyagari(Chief Executive Officer)in

BoardRichel Liu(Director)Deng Mao(Director)inHirak Parikh(Director)

Co-investorsAUAugment Ventures

Astoria, US

Demetrius Michael Karagas(Executive Officer, Director)SGSteven Gutentag(Founder)inDemetri Karagas(Founder)

BoardRKRebecca Kaden(Director)in

Co-investorsALAlpha PartnersALAlumni VenturesCOComcast VenturesCOConnetic VenturesCVCVS Health VenturesEVEvolution VC Partners+19 more

Transforming the lives of patients through a functional cure for Type 1 Diabetes

BiotechSan Diego, US

Brittany Bradrick(Executive Officer)Anne Sandan(Executive Officer)Elizabeth Bui(Executive Officer)Steve White(Executive Officer)HFHoward Foyt(Executive Officer)inKevin D'Amour(Executive Officer)in

Co-investorsARArtis VenturesATATEL VenturesBABain Capital Life SciencesRARA CapitalSASanderling VenturesTHThe Vertical Group+1 more

Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions.

AI & Machine LearningDigital HealthHealthtechBaltimore, US

RSRyan Sysko(Executive Officer, Director)inSCSuzanne Clough(Executive Officer)inKMKevin McRaith(President and CEO)inAIAnand Iyer(Chief AI Officer)inCBChris Bergstrom(Executive Officer)in

BoardTerry Lierman(Director)

Co-investorsMEMerck Global Health Innovation FundSASamsung VenturesASAsset Management CompanyDIDigiTx Partners LLCEXExcel Venture ManagementMSMSD Global Health Innovation Fund+2 more

Yup is a cross-posting tool that lets users publish a single post to multiple social platforms—including Twitter, Farcaster, Lens, and Bluesky—with one click.

Crypto & Web3Social

Co-investorsLDLD CapitalSESevenX Ventures